Advertisement
Advertisement
BAX
Baxter International Inc.
17.70
USDSponsored
-0.90
-4.85%
Mar 06, 15:59 UTC -5
Closed
After-Market
17.98
+0.29
+1.62%
BAX Earnings Reports
Positive Surprise Ratio
BAX beat 32 of 40 last estimates.
80%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.64B
/$0.31
Implied change from Q4 25 (Revenue/ EPS)
-11.09%
/-29.55%
Implied change from Q1 25 (Revenue/ EPS)
+0.74%
/-43.64%
Baxter International Inc. earnings per share and revenue
On Feb 12, 2026, BAX reported earnings of 0.44 USD per share (EPS) for Q4 25, missing the estimate of 0.54 USD, resulting in a -18.73% surprise. Revenue reached 2.97 billion, compared to an expected 2.85 billion, with a 4.28% difference. The market reacted with a -15.99% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 0.31 USD, with revenue projected to reach 2.64 billion USD, implying an decrease of -29.55% EPS, and decrease of -11.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Agilent Technologies Inc.
Report Date
Feb 25, 2026 For Q1 26
Estimate
$1.39
Actual
$1.36
Surprise
-2.58%
Lantheus Holdings, Inc
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.19
Actual
$1.67
Surprise
+40.22%
BillionToOne, Inc. Class A Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.08
Actual
$0.11
Surprise
+27.02%
PERRIGO COMPANY PLC
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.79
Actual
$0.77
Surprise
-4.88%
BioLife Solutions Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.02
Actual
$0.22
Surprise
+1095.48%
Cerus Corp
Report Date
Mar 02, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.01
Surprise
-29.87%
Viemed Healthcare, Inc. Common Shares
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+10.85%
Evolus, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Quanterix Corporation Common Stock
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.45
Actual
-$0.38
Surprise
+17.21%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.12
Surprise
+9.50%
FAQ
What were Baxter International Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Baxter International Inc. reported EPS of $0.44, missing estimates by -18.73%, and revenue of $2.97B, 4.28% above expectations.
How did the market react to Baxter International Inc.'s Q4 2025 earnings?
The stock price moved down -15.99%, changed from $22.27 before the earnings release to $18.71 the day after.
When is Baxter International Inc. expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for Baxter International Inc.'s next earnings report?
Based on 11
analysts, Baxter International Inc. is expected to report EPS of $0.31 and revenue of $2.64B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement